Work

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells

Year: 2017

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-17-0104

Authors: Pol Gimenez-Xavier, Eva Pros, Ester Bonastre, Sebastian Moran, Ana Aza, Osvaldo Graña, Gonzalo Gomez-Lopez, Sophia Derdak, Marc Dabad, Anna Esteve-Codina, Jose R. Hernandez Mora, Diana Salinas-Chaparro, Manel Esteller, David Pisano, Montse Sanchez-Cespedes

Institutions: Institut d'Investigació Biomédica de Bellvitge, Spanish National Cancer Research Centre, Universitat Pompeu Fabra, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Institució Catalana de Recerca i Estudis Avançats

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of Biomedical Innovation, National Institutes of Biomedical Innovation, Health and Nutrition

OpenAlex ID: W2605481248

FWCI: 3.497

Cites: 42

Cited by: 28

Related to: 10